Development of The American Society of Colon and Rectal Surgeons’ Rectal Cancer Surgery Checklist

Glasgow, Sean C.; Morris, Arden M.; Baxter, Nancy N.; Fleshman, James W.; Alavi, Karim; Luchtefeld, Martin; Monson, J. R. T.; Chang, George J.; Temple, Larissa K.

doi:10.1097/dcr.0000000000000606

Cited by 24 publications

(15 citation statements)

References 11 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In patients treated for locally advanced rectal cancer, we could not detect any statistically significant difference in baseline characteristics, efficacy, and safety data compared with the trial of Hofheinz et al We attribute this finding to highly standardized staging, chemotherapy, and surgery protocols for locally advanced rectal cancer …”

Section: Discussionmentioning

confidence: 66%

“Real‐life” outcome of gastrointestinal tumor therapies: A single‐center comparative study

Buratti

Mair²,

Mühlberger³

et al. 2019

Cancer Reports

View full text Add to dashboard Cite

Background: Despite of the ongoing improvements in gastrointestinal oncology, it remains unclear whether results of randomized controlled trials are achievable in daily clinical practice of nonacademic environments. Aim: This study aims at assessing a potential efficacy-effectiveness gap in gastrointestinal cancer treatment. Methods and Results: Data from 656 gastrointestinal cancer patients treated between 2007 and 2015 in a medium-sized, nonacademic day hospital oncology unit in Italy were analyzed. Probability of survival and median overall survival as efficacy indicators and the occurrence of grades 3 to 4 adverse events as safety indicators were compared with randomized phase II/III trials of respective entities. Outcomes were well comparable between published data and the real-life setting. In resectable gastroesophageal cancer, 1-year survival after treatment initiation was greater (relative risks [RR] = 1.3, p = .007), while patients with adjuvant chemotherapy for pancreatic cancer exhibited inferior 2-year survival (RR = 0.7, p = .048) compared withreferenced trials. At our unit, neutropenia was less frequent (5.8% vs 27.8%, p = .039) in palliative chemotherapy for pancreatic cancer, as was peripheral neuropathy for stage II/III colon cancer (3.9% vs 12.5%, p = .027). Conclusion:The "real-life" findings of this study support the efficacy and safety data achieved in landmark trials of gastrointestinal oncology.

show abstract

Section: Discussionmentioning

confidence: 66%

“Real‐life” outcome of gastrointestinal tumor therapies: A single‐center comparative study

Buratti

Mair²,

Mühlberger³

et al. 2019

Cancer Reports

View full text Add to dashboard Cite

show abstract

“…(12, 13) In fact, the high degree of variability we note among surgeons is precisely why the checklist was created – to provide a tool for rectal cancer care standardization. (8) Therefore, proponents of centralized rectal cancer centers must recognize that simply referring patients to specialty centers – such as the site of this study – will not alone improve treatment variability. Instead, comprehensive efforts including additional initiatives like physician education, mandatory outcomes reporting, and creation of validated point-of-care decision support tools must also be considered.…”

Section: Discussionmentioning

confidence: 99%

“…(8) Each item from the checklist served as a variable for initial analysis. Items completed across all surveyed patients represented “Complete Compliance.” Among all patients, the median number of completed checklist items was 21.…”

Section: Methodsmentioning

confidence: 99%

See 1 more Smart Citation

Benchmarking rectal cancer care: institutional compliance with a longitudinal checklist

Chapman

Choi

Hawkins

et al. 2018

Journal of Surgical Research

Self Cite

View full text Add to dashboard Cite

Background In 2012, the American Society of Colon and Rectal Surgeons published the Rectal Cancer Surgery Checklist, a consensus document listing 25 essential elements of care for all patients undergoing radical surgery for rectal cancer. The authors herein examine checklist adherence among a mature, multi-surgeon specialty academic practice. Materials and Methods A retrospective medical record review of patients undergoing elective radical resection for rectal adenocarcinoma over a 23-month period was conducted. Checklists were completed post hoc for each patient, and these results were tabulated to determine levels of compliance. Subgroup analyses by compliance levels and experience level of the treating surgeon were performed. Results 161 patients underwent resection, demonstrating a median completion rate of 84% per patient. Poor compliance was noted consistently in documenting baseline sexual function (0%), multidisciplinary discussion of treatment plans (16.8%), pelvic nerve identification (8.7%) and leak testing (52.9%), and radial margin status reporting (57.5%). Junior surgeons achieved higher rates of compliance and were more likely to restage following neoadjuvant therapy (67.9% vs 29.4%, p < 0.001), discuss patients at tumor board (31.3% vs 13.2%, p=0.014), and document leak testing (86.7% vs 47.2%, p=0.005) compared to senior surgeons. Conclusions Checklist compliance within a high-volume, specialty academic practice remains varied. Only surgeon experience level was significantly associated with high checklist compliance. Junior surgeons achieved greater compliance with certain items, particularly those that reinforce decision-making. Further efforts to standardize rectal cancer care should focus on checklist implementation, targeted surgeon outreach, and assessment of checklist compliance correlation to clinical outcomes.

show abstract

“…It encompasses the total care of the rectal cancer patient. The checklist promotes discipline and encourages higher performance in treating patients with rectal cancer [6]. It is another tool to help move forward in standardizing care for this complex, multidiscipline disease.…”

mentioning

confidence: 99%

Standardizing Rectal Cancer Care in the United States

Galler¹

2016

JCPCR

View full text Add to dashboard Cite

show abstract

Development of The American Society of Colon and Rectal Surgeons’ Rectal Cancer Surgery Checklist

Cited by 24 publications

References 11 publications

“Real‐life” outcome of gastrointestinal tumor therapies: A single‐center comparative study

“Real‐life” outcome of gastrointestinal tumor therapies: A single‐center comparative study

Benchmarking rectal cancer care: institutional compliance with a longitudinal checklist

Standardizing Rectal Cancer Care in the United States

Contact Info

Product

Resources

About